butabarbital decreases consequences of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Intently. Coadministration of CYP3A4 inducers may perhaps minimize sufentanil stages and efficacy, probably precipitating withdrawal syndrome in people who've formulated physical dependence to sufentanil. Di